PanCystPro™
Risk stratification of pancreatic cystic lesions for pancreatic cancer
Key Facts
About Amplified Sciences
Amplified Sciences is a private, clinical-stage diagnostics company leveraging a proprietary ultra-sensitive optical reporter platform to create a new class of multi-omics diagnostic tests. Its lead program, PanCystPro™, is a diagnostic test designed to analyze pancreatic cyst fluid to stratify cancer risk in patients with pancreatic cystic lesions, addressing a critical unmet need in early pancreatic cancer detection. The company is positioned in the high-growth molecular diagnostics market, aiming to provide clinicians with tools for more accurate and earlier intervention in debilitating diseases. As a pre-revenue entity, its near-term focus is on clinical validation and commercial preparation for its lead assay.
View full company profile